Cited In for PMID: 22607556

Year	Number of Results
2012	3
2013	5
2014	4
2015	6
2016	3
2017	1
2018	2
2019	4
2020	1
2021	2
2022	1
2024	0

1

Combinations of griffithsin with other carbohydrate-binding agents demonstrate superior activity against HIV Type 1, HIV Type 2, and selected carbohydrate-binding agent-resistant HIV Type 1 strains.

Férir G, Huskens D, Palmer KE, Boudreaux DM, Swanson MD, Markovitz DM, Balzarini J, Schols D. Férir G, et al. AIDS Res Hum Retroviruses. 2012 Nov;28(11):1513-23. doi: 10.1089/AID.2012.0026. Epub 2012 Jun 25. AIDS Res Hum Retroviruses. 2012. PMID: 22607556 Free PMC article.

2

An Update of Lectins from Marine Organisms: Characterization, Extraction Methodology, and Potential Biofunctional Applications.

Ahmmed MK, Bhowmik S, Giteru SG, Zilani MNH, Adadi P, Islam SS, Kanwugu ON, Haq M, Ahmmed F, Ng CCW, Chan YS, Asadujjaman M, Chan GHH, Naude R, Bekhit AEA, Ng TB, Wong JH. Ahmmed MK, et al. Mar Drugs. 2022 Jun 29;20(7):430. doi: 10.3390/md20070430. Mar Drugs. 2022. PMID: 35877723 Free PMC article. Review.

3

Algal and Cyanobacterial Lectins and Their Antimicrobial Properties.

Fernández Romero JA, Paglini MG, Priano C, Koroch A, Rodríguez Y, Sailer J, Teleshova N. Fernández Romero JA, et al. Mar Drugs. 2021 Dec 1;19(12):687. doi: 10.3390/md19120687. Mar Drugs. 2021. PMID: 34940686 Free PMC article. Review.

4

Preformulation Characterization of Griffithsin, a Biopharmaceutical Candidate for HIV Prevention.

Kramzer LF, Hamorsky KT, Graebing PW, Wang L, Fuqua JL, Matoba N, Lasnik AB, Moncla BJ, Zhang J, Palmer KE, Rohan LC. Kramzer LF, et al. AAPS PharmSciTech. 2021 Feb 24;22(3):83. doi: 10.1208/s12249-021-01931-0. AAPS PharmSciTech. 2021. PMID: 33625602 Free PMC article.

5

Pharmaceutical Approaches to HIV Treatment and Prevention.

Yavuz B, Morgan JL, Showalter L, Horng KR, Dandekar S, Herrera C, LiWang P, Kaplan DL. Yavuz B, et al. Adv Ther (Weinh). 2018 Oct;1(6):1800054. doi: 10.1002/adtp.201800054. Epub 2018 Jul 29. Adv Ther (Weinh). 2018. PMID: 32775613 Free PMC article.

6

Sustained-release Griffithsin nanoparticle-fiber composites against HIV-1 and HSV-2 infections.

Tyo KM, Lasnik AB, Zhang L, Mahmoud M, Jenson AB, Fuqua JL, Palmer KE, Steinbach-Rankins JM. Tyo KM, et al. J Control Release. 2020 May 10;321:84-99. doi: 10.1016/j.jconrel.2020.02.006. Epub 2020 Feb 5. J Control Release. 2020. PMID: 32035194 Free PMC article.

7

Griffithsin Retains Anti-HIV-1 Potency with Changes in gp120 Glycosylation and Complements Broadly Neutralizing Antibodies PGT121 and PGT126.

Fischer K, Nguyen K, LiWang PJ. Fischer K, et al. Antimicrob Agents Chemother. 2019 Dec 20;64(1):e01084-19. doi: 10.1128/AAC.01084-19. Print 2019 Dec 20. Antimicrob Agents Chemother. 2019. PMID: 31611356 Free PMC article.

8

Griffithsin, a Highly Potent Broad-Spectrum Antiviral Lectin from Red Algae: From Discovery to Clinical Application.

Lee C. Lee C. Mar Drugs. 2019 Oct 6;17(10):567. doi: 10.3390/md17100567. Mar Drugs. 2019. PMID: 31590428 Free PMC article. Review.

9

Mannose-Specific Lectins from Marine Algae: Diverse Structural Scaffolds Associated to Common Virucidal and Anti-Cancer Properties.

Barre A, Simplicien M, Benoist H, Van Damme EJM, Rougé P. Barre A, et al. Mar Drugs. 2019 Jul 26;17(8):440. doi: 10.3390/md17080440. Mar Drugs. 2019. PMID: 31357490 Free PMC article. Review.

10

Overview of the Structure⁻Function Relationships of Mannose-Specific Lectins from Plants, Algae and Fungi.

Barre A, Bourne Y, Van Damme EJM, Rougé P. Barre A, et al. Int J Mol Sci. 2019 Jan 10;20(2):254. doi: 10.3390/ijms20020254. Int J Mol Sci. 2019. PMID: 30634645 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

29 results

Results by year